Baidyanath's Traditional Ayurveda Brand Strategy

Industry & Competitive Context

India's organised Ayurveda and herbal FMCG segment is dominated by a small set of legacy players, the most prominent being Dabur India, Patanjali Ayurved, Himalaya, Zandu (Emami), and Baidyanath. Dabur describes itself as the "world's largest Ayurvedic and Natural Health Care Company" and the fourth-largest FMCG company in India, with a portfolio of over 250 herbal and Ayurvedic products spanning healthcare, personal care, and foods. Within the Chyawanprash sub-category specifically — a fermented herbal jam positioned as an immunity tonic — Dabur is the established category leader. In its own annual report and management discussion, Dabur disclosed that Dabur Chyawanprash ended a recent fiscal year with its "highest-ever market share of 65.8%," a gain of 140 basis points, even as overall category offtake was affected by a shorter winter season. Patanjali Ayurved entered this landscape in the 2010s as a disruptive, swadeshi-positioned FMCG challenger that combined aggressive pricing with large-scale traditional and digital marketing, materially altering competitive dynamics across the Ayurveda and natural-products category. Industry commentary from digital marketing agencies (Digitale) notes that established players including Hindustan Unilever, Dabur, Baidyanath, and smaller D2C entrants such as Kapiva subsequently increased their own investment in digital channels to defend share and visibility in a category that was becoming more contested and more digitally discovered. Against this backdrop, Baidyanath — one of India's oldest Ayurvedic manufacturers — occupies a position as a heritage, formulation-led brand with deep manufacturing scale but a comparatively smaller and less digitally visible consumer marketing footprint than Dabur or Patanjali, particularly prior to the early 2020s.

Brand Situation Prior to the Campaign

Shree Baidyanath Ayurved Bhawan Pvt. Ltd. was established in 1917 in Kolkata by two brothers, Pandit Ram Narayan Sharma and Pandit Ram Dayal Joshi. According to company and press accounts, the venture was conceived partly as a nationalist response to the dominance of Western and foreign-made medicines in colonial India, with the founders seeking to preserve and scientifically validate classical Ayurvedic knowledge. From its Kolkata base, the company expanded manufacturing to Patna (1940), Jhansi (1941), Nagpur (1942), and Prayagraj/Allahabad (1958), and later added units at Baddi, Barotiwala, Kashipur, and Seoni. By the time of its centenary, Baidyanath described itself as a manufacturer of more than 700 Ayurvedic formulations and the publisher of Ayurved Sar Sangraha, a formulation reference work that the company states is recognised under the First Schedule of the Drugs and Cosmetics Act, 1940 — situating Baidyanath's knowledge base within India's formal pharmacopoeial framework rather than purely folk tradition. The company has historically operated as a closely held, family-run business; Vicram Sharma, a third-generation family member and graduate of the London School of Economics, has been identified in press profiles (IBTimes India, The Patriot) as having joined the family business around 2013 and subsequently taken on a leadership role aimed at modernising the company's operations and outlook while preserving its classical positioning. Trade and business-directory sources describe Baidyanath's commercial footprint at scale: one company filing referenced via IndiaMart records an annual turnover exceeding ₹500 crore and distribution through more than 100,000 retail outlets, while third-party private-company databases (Tracxn) estimate later-year revenue figures in the same broad range. These figures originate from business-intelligence aggregators and self-declared filings rather than audited, publicly released financial statements, and should be read with that caveat. Despite this manufacturing and distribution scale, multiple trade press and marketing-agency accounts converge on a consistent narrative: Baidyanath, unlike Dabur or Patanjali, had a comparatively limited brand-building and digital presence going into the COVID-19 period. A digital agency case study (Strongly Positive) that worked with the brand explicitly frames the challenge it was engaged to solve as twofold — establishing that a "century-old" brand could "stand for its legacy, yet be relevant for today," and "establish[ing] credibility of being Asli Ayurveda" in a category where authenticity claims are heavily contested — while noting the brand "was late to start its Social Media game."

Strategic Objective

Based on statements made by Baidyanath's own leadership in trade press interviews, the brand's stated strategic objective in its most documented marketing initiative was twofold:

1. Category repositioning: to shift consumer evaluation criteria for Chyawanprash away from a "low involvement and undifferentiated category" purchase (in the words of Grey Group's Chief Operating Officer, Ketan Desai) toward an informed, process-and-ingredient-led decision.

   
   

2. Brand modernisation without dilution of heritage: to make a century-old, formulation-heavy brand relevant to a contemporary, increasingly digital-first consumer base, while continuing to anchor credibility in classical Ayurvedic texts and manufacturing process.

   
   

Baidyanath's Director, Ajay Sharma, framed the campaign's purpose as enabling consumers "to make an informed choice & check what goes inside their Chyawanprash brand," explicitly positioning the brand as an educator on category standards rather than only a product seller. CMO Ramesh Yadav further stated the objective was "to reposition the category and shift the focus of the conversation from ingredients to the process" of manufacture.

Campaign Architecture & Execution

The most extensively documented Baidyanath marketing initiative in public sources is the "Sahi Vidhi, Behtar Immunity" ("Right Method, Better Immunity") campaign for Baidyanath Chyawanprash, conceptualised and executed by Grey Group and launched in November 2021, during the COVID-19 pandemic period.

Brand ambassador. The campaign introduced Pankaj Tripathi, a widely recognised Hindi-film and OTT actor, as Baidyanath's first major brand ambassador, with actor Girija Oak playing his on-screen wife. According to Baidyanath's CMO, Tripathi was selected because he was already a long-standing personal user of Baidyanath products and was perceived by the brand as embodying "authentic, simple, effortless" values consistent with the brand's positioning; the company also noted his broad relatability rooted in his "Hindi heartland" background and public persona.

Creative execution. Trade press analysis (afaqs) of the television commercial describes a narrative built around a domestic, relatable scenario, using a cricket-scoring metaphor — Tripathi's character insisting "we will only win if we make baavan [52] runs," not bayallis [42] — to communicate that Baidyanath Chyawanprash contains 52 Ayurvedic ingredients, contrasted implicitly against a rival's stated count of "more than 41 Ayurvedic herbs" (a figure the article attributes to Dabur's own website at the time). The execution thus converted a numeric formulation claim into a memorable, culturally resonant device rather than a dry ingredient list, while avoiding direct brand-naming of the competitor.

Integrated nature of the campaign. Press coverage (MxMIndia, MediaBrief, BestMediaInfo, MediaInfoLine) describes the initiative as an "integrated campaign," indicating deployment across multiple formats and channels rather than a single television spot, though none of these sources discloses a specific media plan, channel mix percentages, or spend figures.

No verified public information is available on the campaign's media budget, flighting schedule, or precise channel allocation (e.g., television GRPs, digital spend split, OOH presence).

Positioning & Consumer Insight

The underlying consumer insight articulated by Baidyanath's own marketing leadership centres on category-level disengagement and information asymmetry. Grey Group's Ketan Desai characterised Chyawanprash, prior to the campaign, as "an otherwise low involvement and undifferentiated category" — implying that consumers historically purchased on habit, availability, or price rather than active evaluation of formulation or process. The "Sahi Vidhi" (right method) framing sought to convert this into a high-involvement, comparison-driven decision by introducing two evaluation axes that favoured Baidyanath's stated strengths: (a) ingredient count/composition, and (b) adherence to classical preparation method, an area where Baidyanath's century-long manufacturing heritage and codified formulary (Ayurved Sar Sangraha) provided a credible, defensible claim relative to newer or more industrially produced competitors. CMO Ramesh Yadav explicitly linked this positioning to manufacturing practice, stating that Baidyanath continues to use "particular wooden spatulas from old texts" in Chyawanprash production and that the company has built "in-house machines that replicate historical procedures" based on its codified texts — directly translating an abstract "authenticity" claim into a concrete, communicable production detail. The pandemic context (2020–2021) is treated in company statements as a category tailwind rather than a campaign-created demand state: Yadav noted that as "Ayurvedic manufacturers, we realized we needed to step up" in response to heightened consumer interest in immunity-related products during COVID-19, situating the campaign as a response to, rather than the origin of, increased category salience. The brand's positioning statement, as stated by the Director, was that Baidyanath should be understood as "the most authentic and complete Chyawanprash" — a claim built on the dual pillars of formulation completeness (ingredient count) and procedural fidelity (method), rather than price, taste, or modern packaging.

Media & Channel Strategy

Verified public information on Baidyanath's media and channel approach is limited to the following documented elements:

• Television/integrated advertising: The "Sahi Vidhi, Behtar Immunity" campaign was executed as an integrated campaign by Grey Group, anchored by a televised commercial featuring Pankaj Tripathi and Girija Oak (per MxMIndia, MediaBrief, BestMediaInfo, and afaqs coverage from November 2021).

  
  

• Digital and social media: A separate, named digital marketing engagement (Strongly Positive, a Mumbai-based agency) describes work undertaken for Baidyanath covering social media strategy, social media management, website banner design, performance marketing creatives, and brand identity elements (colour palette and typography), framed around building an Instagram content narrative centred on ingredients, remedies, and Ayurvedic science. This is presented in the source as agency-authored case-study material describing client work, not as a Baidyanath corporate disclosure, and should be read with that distinction in mind.

  
  

• Lead generation and distributor-network advertising: A separate digital agency case study (Nians) states that campaigns for Baidyanath incorporated lead-generation advertising intended to expand the brand's distributor network, alongside content tie-ins referencing Bollywood films, executed across what the agency describes as an "omni-channel" approach. As with the above, this is agency-sourced case-study material rather than a company filing or press release, and specific platform-level budgets are not disclosed in the source.

  
  

• Historical/heritage advertising formats: Earlier-era marketing activity, as referenced in secondary commentary (a Medium retrospective on Ayurveda advertising) and an unrelated academic/student analysis of a separate Baidyanath product line (Sundari Sakhi, examined in a regional market study), indicates the brand has historically also relied on newspaper advertising and outdoor formats such as banners and posters in specific regional markets (e.g., Nagpur). These references describe localised, dated market conditions and are not generalisable to the brand's national or current media strategy.

  
  

Business & Brand Outcomes

The clearest self-reported market-position claim available is from CMO Ramesh Yadav, who stated at the time of the campaign launch that Baidyanath Chyawanprash was, "backed by years of research," the "second-largest Chyawanprash brand in India, with a large number of loyal user base across the country." This is a company executive's public statement reported in trade press (MediaInfoLine, MediaBrief) rather than data drawn from an audited report, market research syndication (e.g., Nielsen, Kantar), or regulatory filing, and no independent corroborating source with category-wide market-share figures for Baidyanath specifically was identified in this research. By contrast, Dabur's own annual report figures (Section 1) place Dabur Chyawanprash's category share at 65.8%, which independently establishes Dabur as the clear category leader but does not itself confirm or quantify Baidyanath's rank-two position.

Strategic Implications

Three strategic patterns can be drawn directly from the verified record, without extrapolation beyond what is documented.

First, heritage was operationalised as a comparative claim, not merely a brand story. Rather than relying on "since 1917" as an abstract trust signal — a tactic common across legacy Indian FMCG brands — Baidyanath's CMO and the campaign's creative both converted heritage into specific, falsifiable claims: a named classical text (Ayurved Sar Sangraha), a specific production tool (wooden spatulas), and a countable ingredient figure (52) set in implicit contrast to a named competitor's lower count. This reflects a positioning choice to compete on demonstrable process fidelity in a category the brand's own agency partner described as low-involvement — using specificity to manufacture differentiation where functional product differences may otherwise be difficult for consumers to assess.

Second, ambassador selection was explicitly value-congruence-led rather than reach-led. Multiple company statements emphasise that Pankaj Tripathi was chosen because of his prior personal use of the brand and his public image of authenticity and approachability, rather than for raw celebrity reach or box-office scale. This is consistent with a broader pattern in Indian FMCG advertising of the early 2020s, where "relatable everyman" actors (Tripathi was concurrently associated with brands such as Policybazaar, Cadbury Fuse, and Fino Payments Bank, per trade press) were used to lend credibility to categories — banking, confectionery, healthcare — where consumer trust rather than aspiration was the primary barrier to purchase.

Third, the brand's digital and performance marketing efforts (per agency case studies) appear to have been organised around addressing a structural lag: multiple independent agency accounts converge on the characterisation that Baidyanath entered digital and social channels later than comparable competitors. The verified record shows this was addressed through parallel workstreams — a centrally produced, ambassador-led mass-media campaign (Grey Group) for category repositioning, alongside separate, owned/social-channel-focused digital execution (Strongly Positive, Nians) aimed at content credibility and distributor-network lead generation. This suggests a brand attempting to close a digital visibility gap against better-resourced rivals (Dabur, Patanjali) without abandoning the formulation-and-heritage positioning that differentiates it from mass-market FMCG challengers.

The overall implication for brand strategy is that in a category where competitors can credibly contest "natural" or "Ayurvedic" claims, the more defensible competitive asset for a legacy player is documented procedural and formulary specificity — a strategy that converts the passage of time (a century of operation) into present-tense, comparison-ready claims, rather than treating heritage as a static, undifferentiated badge.

Discussion Questions

1. Baidyanath chose to compete on ingredient count and procedural fidelity ("Sahi Vidhi") rather than price or modern reformulation. Given Dabur's dominant 65.8% category share, evaluate whether a differentiation-on-authenticity strategy is a sustainable basis for share gain in a category led by a much larger incumbent.

   
   

2. Multiple sources indicate Baidyanath was a "late mover" in digital and social media relative to Patanjali and Dabur. What are the risks and potential advantages of a legacy brand sequencing a mass-media ambassador campaign (Grey Group/Pankaj Tripathi) alongside, rather than after, building owned digital/social channels?

   
   

3. The campaign's central comparative claim (52 ingredients vs. a competitor's 41) was delivered through a cricket metaphor rather than direct competitor naming. Assess this creative choice from the standpoint of both regulatory/advertising-standards risk and persuasive effectiveness in a low-involvement category.

   
   

4. Baidyanath is a privately held, family-run company without publicly disclosed audited financials, in contrast to listed competitor Dabur. Discuss how the absence of public financial disclosure constrains external evaluation of brand strategy effectiveness, and what alternative public signals (e.g., executive statements, agency case studies, retail distribution claims) stakeholders must rely on instead.

   
   

5. Vicram Sharma, a third-generation, internationally educated family member, has been publicly associated with modernising Baidyanath's outlook. What governance and brand-stewardship tensions typically arise when a multi-generational family business attempts to modernise marketing and digital strategy while preserving a heritage-and-authenticity positioning, and how might this be managed?